TUKYSA 50 mg film-coated tablets, TUKYSA 150 mg film-coated tablets
GEICAM/2020-08
Phase 2 small_molecule active
Quick answer
TUKYSA 50 mg film-coated tablets, TUKYSA 150 mg film-coated tablets for Non-resectable locally advanced or metastatic HER2-positive breast cancer is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Non-resectable locally advanced or metastatic HER2-positive breast cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active